FDA Expert Says GSK In Charge Of Paxil Label Changes
A former U.S. Food and Drug Administration medical reviewer pushed forward the narrative of a Reed Smith LLP partner's widow Tuesday by telling an Illinois federal jury that Paxil manufacturer GlaxoSmithKline...To view the full article, register now.
Already a subscriber? Click here to view full article